Clinical Trial

Extending the Time Window for Intravenous Tenecteplase in Patients With Distal Medium Vessel Occlusions Stroke

Recruiting
View on ClinicalTrials.gov →
Summary
To assess the safety and efficacy of beyond time window TNK intravenous thrombolysis for distal Medium Vessel Occlusion (MeVO) related stroke in a prospective randomized clinical trial.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-15.
Trial Details
NCT Number NCT06559436
Lead Sponsor The First Affiliated Hospital of University of Science and Technology of China
Conditions Acute Ischemic Stroke
Enrollment 560 participants
Start Date 2024-10-02
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-24